Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Chosa Oncology AB

Closing information (x1000 EUR)

Closing information 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Turnover 0 Equal arrow 0 Equal arrow 0
Financial expenses 49 More Arrow 133 Less Arrow 22
Earnings before taxes -2,141 Less Arrow -3,694 Less Arrow -6,070
EBITDA -2,050 Less Arrow -3,695 Less Arrow -6,048
Total assets 1,751 More Arrow 2,506 More Arrow 5,459
Current assets 858 More Arrow 2,506 More Arrow 5,459
Current liabilities 182 More Arrow 1,693 Less Arrow 1,382
Equity capital 1,569 Less Arrow 813 More Arrow 4,077
- share capital 1,052 Less Arrow 308 More Arrow 335
Employees (average) 1 More Arrow 4 Equal arrow 4

Financial ratios

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Solvency 89.6% Less Arrow 32.4% More Arrow 74.7%
Turnover per employee 0 Equal arrow 0 Equal arrow 0
Profit as a percentage of turnover
Return on assets (ROA) -119.5% Less Arrow -142.1% More Arrow -110.8%
Current ratio 471.4% Less Arrow 148.0% More Arrow 395.0%
Return on equity (ROE) -136.5% Less Arrow -454.4% More Arrow -148.9%
Change turnover 0 Equal arrow 0 Equal arrow 0
Change turnover %
Chg. No. of employees -3 More Arrow 0 More Arrow 1
Chg. No. of employees % -75% More Arrow 0% More Arrow 33%

Total value of public sale

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.